These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 3351230)

  • 1. Histogenesis of Dupuytren's disease: an immunohistochemical study of 30 cases.
    Shum DT; McFarlane RM
    J Hand Surg Am; 1988 Jan; 13(1):61-7. PubMed ID: 3351230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of myofibroblasts in the dermis of patients with Dupuytren's contracture. A possible source for recurrence.
    McCann BG; Logan A; Belcher H; Warn A; Warn RM
    J Hand Surg Br; 1993 Oct; 18(5):656-61. PubMed ID: 8294839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Appearance of the myofibroblastic phenotype in Dupuytren's disease is associated with a fibronectin, laminin, collagen type IV and tenascin extracellular matrix.
    Berndt A; Kosmehl H; Katenkamp D; Tauchmann V
    Pathobiology; 1994; 62(2):55-8. PubMed ID: 7524526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of pro-inflammatory cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a possible future therapeutic strategy?
    Bianchi E; Taurone S; Bardella L; Signore A; Pompili E; Sessa V; Chiappetta C; Fumagalli L; Di Gioia C; Pastore FS; Scarpa S; Artico M
    Clin Sci (Lond); 2015 Oct; 129(8):711-20. PubMed ID: 26201022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An investigation into the role of inflammatory cells in Dupuytren's disease.
    Andrew JG; Andrew SM; Ash A; Turner B
    J Hand Surg Br; 1991 Aug; 16(3):267-71. PubMed ID: 1960491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dupuytren's disease. A model for the mechanism of fibrosis and its modulation by steroids.
    Meek RM; McLellan S; Crossan JF
    J Bone Joint Surg Br; 1999 Jul; 81(4):732-8. PubMed ID: 10463754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptors in Dupuytren's contracture.
    Pagnotta A; Specchia N; Greco F
    J Orthop Res; 2002 Jan; 20(1):163-8. PubMed ID: 11853085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
    Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
    Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence of myofibroblasts in the different phases of morbus Dupuytren (Dupuytren's contracture).
    Gokel JM; Hübner G
    Beitr Pathol; 1977 Oct; 161(2):166-75. PubMed ID: 597102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of bone morphogenetic proteins by Dupuytren's fibroblasts.
    Shin SS; Liu C; Chang EY; Carlson CS; Di Cesare PE
    J Hand Surg Am; 2004 Sep; 29(5):809-14. PubMed ID: 15465229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of expression of alpha-smooth muscle actin in cells of Dupuytren's contracture.
    Hindman HB; Marty-Roix R; Tang JB; Jupiter JB; Simmons BP; Spector M
    J Bone Joint Surg Br; 2003 Apr; 85(3):448-55. PubMed ID: 12729127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in sera and tissue of patients with Dupuytren's disease.
    Ulrich D; Hrynyschyn K; Pallua N
    Plast Reconstr Surg; 2003 Oct; 112(5):1279-86. PubMed ID: 14504511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pathogenesis of Dupuytren's contracture--a review].
    Koźma EM; Olczyk K; Bobiński R; Kasperczyk M; Szpyra K
    Chir Narzadow Ruchu Ortop Pol; 2002; 67(1):73-9. PubMed ID: 12087679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren's disease.
    Alfonso-Rodríguez CA; Garzón I; Garrido-Gómez J; Oliveira AC; Martín-Piedra MÁ; Scionti G; Carriel V; Hernández-Cortés P; Campos A; Alaminos M
    PLoS One; 2014; 9(11):e112457. PubMed ID: 25379672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An insight into Dupuytren's contracture.
    Murrell GA
    Ann R Coll Surg Engl; 1992 May; 74(3):156-60; discussion 161. PubMed ID: 1616255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dupuytren's contracture; increased cellularity--proliferation, is there equality?
    Forsman M; Kallioinen L; Kallioinen M; Ryhänen J
    Scand J Surg; 2005; 94(1):71-5. PubMed ID: 15865122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in alpha smooth muscle actin expression between fibroblasts derived from Dupuytren's nodules or cords.
    Dave SA; Banducci DR; Graham WP; Allison GM; Ehrlich HP
    Exp Mol Pathol; 2001 Oct; 71(2):147-55. PubMed ID: 11599921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of alpha-smooth muscle actin expression and contraction in Dupuytren's disease fibroblasts.
    Tomasek J; Rayan GM
    J Hand Surg Am; 1995 May; 20(3):450-5. PubMed ID: 7642925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular "fibrous long spacing" collagen in morbus dupuytren (Dupuytren's contracture).
    Gokel JM; Hübner G
    Beitr Pathol; 1977 Oct; 161(2):176-86. PubMed ID: 597103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The myofibroblast in Dupuytren's contracture.
    Rudolph R; Vande Berg J
    Hand Clin; 1991 Nov; 7(4):683-92; discussion 693-4. PubMed ID: 1769990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.